Bio-Techne Corporation vs Alkermes plc: Annual Revenue Growth Compared

Bio-Techne Corporation vs Alkermes plc: A Decade of Revenue Growth

In the ever-evolving biotech industry, revenue growth is a key indicator of a company's success and market position. Over the past decade, Bio-Techne Corporation and Alkermes plc have demonstrated notable revenue trajectories. From 2014 to 2023, Alkermes plc saw its revenue grow by approximately 169%, starting from $618 million to a peak of $1.66 billion in 2023. Meanwhile, Bio-Techne Corporation experienced a robust growth of around 218%, with revenues increasing from $358 million in 2014 to $1.14 billion in 2023.

Despite a dip in 2020, both companies rebounded strongly, with Bio-Techne surpassing the $1 billion mark in 2022. The data for 2024 is incomplete, but Bio-Techne's consistent upward trend suggests continued growth. This comparison highlights the dynamic nature of the biotech sector and the resilience of these companies in navigating market challenges.